These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23713044)

  • 1. Liver metastasectomy after neo adjuvant chemotherapy in colorectal cancer: a word of caution.
    Chandrasekar SK; Seshadri RA; Majhi U
    Indian J Cancer; 2013; 50(1):45. PubMed ID: 23713044
    [No Abstract]   [Full Text] [Related]  

  • 2. Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer.
    Hebbar M; Pruvot FR; Romano O; Triboulet JP; de Gramont A
    Cancer Treat Rev; 2009 Dec; 35(8):668-75. PubMed ID: 19733977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy During Pregnancy for Advanced Colon Cancer: A Case Report.
    Frydenberg H; Harsem NK; Ofigsbø Å; Skoglund H; Brændengen M; Kaasa S; Guren MG
    Clin Colorectal Cancer; 2020 Jun; 19(2):141-144. PubMed ID: 32222353
    [No Abstract]   [Full Text] [Related]  

  • 4. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients.
    Komori H; Beppu T; Baba Y; Horino K; Imsung C; Masuda T; Hayashi H; Okabe H; Ootao R; Watanabe M; Takamori H; Iyama K; Baba H
    Int J Clin Oncol; 2010 Jun; 15(3):263-70. PubMed ID: 20238233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.
    Baba K; Oshita A; Kohyama M; Inoue S; Kuroo Y; Yamaguchi T; Nakamura H; Sugiyama Y; Tazaki T; Sasaki M; Imamura Y; Daimaru Y; Ohdan H; Nakamitsu A
    World J Gastroenterol; 2015 Feb; 21(6):1982-8. PubMed ID: 25684967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
    Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
    Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should the results of the new EPOC trial change practice in the management of patients with resectable metastatic colorectal cancer confined to the liver?
    Nordlinger B; Poston GJ; Goldberg RM
    J Clin Oncol; 2015 Jan; 33(3):241-3. PubMed ID: 25403221
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term outcome of unresectable metastatic colorectal cancer: does "adjuvant" chemotherapy play a role after resection?
    Power DG; Kemeny NE
    Ann Surg; 2009 Oct; 250(4):654-5; author reply 655. PubMed ID: 19730229
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ambulatory chemotherapy schedule for metastatic colorectal cancer].
    Watine J; Soulage C
    Presse Med; 2001 Jan; 30(1):35. PubMed ID: 11210587
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver resection after downstaging with neoadjuvant chemotherapy for "unresectable" colorectal metastases].
    Frena A; Martin F; La Guardia G; Vezzali N; Bonatti G; Stocker J; Graiff C
    Chir Ital; 2004; 56(3):351-7. PubMed ID: 15287631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis.
    Ji JH; Park SH; Lee J; Kim TW; Hong YS; Kim KP; Kim SY; Baek JY; Kang HJ; Shin SJ; Shim BY; Park YS
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):223-30. PubMed ID: 23689915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver resection following FOLFOXIRI plus bevacizumab: a detailed pathological review.
    Walter H; Thomas AL
    Br J Cancer; 2013 Jun; 108(12):2417-8. PubMed ID: 23801031
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liver damage detected after a hepatectomy for liver metastasis after 12 courses of mFOLFOX6 therapy as an adjuvant chemotherapy for colorectal cancer].
    Makino S; Murata K; Murakami M; Wada Y; Kato R; Nishigaki T; Owada Y; Okada K; Yanagisawa T; Okamura S; Ebisui C; Yokouchi H; Kinuta M; Nakagomi N; Tamai M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2222-4. PubMed ID: 23268030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of resection of synchronous multiple liver metastases from colorectal cancer after hepatic infusion chemotherapy and systemic chemotherapy].
    Sagawa T; Sato Y; Takayama T; Hirakawa M; Abe S; Iyama S; Miyanishi K; Kawano Y; Takada K; Nakamura T; Kato J; Niitsu Y
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1481-4. PubMed ID: 17876151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
    Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
    Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view.
    Battisti S; Guida FM; Pagliara E; Tonini G; Zobel BB; Santini D
    Clin Colorectal Cancer; 2014 Sep; 13(3):e13-5. PubMed ID: 25085312
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer.
    Kosmider S; Tan TH; Yip D; Dowling R; Lichtenstein M; Gibbs P
    J Vasc Interv Radiol; 2011 Jun; 22(6):780-6. PubMed ID: 21515072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases.
    Masi G; Loupakis F; Pollina L; Vasile E; Cupini S; Ricci S; Brunetti IM; Ferraldeschi R; Naso G; Filipponi F; Pietrabissa A; Goletti O; Baldi G; Fornaro L; Andreuccetti M; Falcone A
    Ann Surg; 2009 Mar; 249(3):420-5. PubMed ID: 19247029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant chemotherapy with FOLFOX4 regimen after curative resection of liver metastases from colorectal cancer].
    Ohnishi T; Kanoh T; Tono T; Danno K; Watanabe A; Nakamura H; Tsukao Y; Inatome J; Kim T; Kagara N; Taniguchi H; Kimura Y; Nakano Y; Monden T; Imaoka S
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2554-6. PubMed ID: 21224637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
    Garant A; Des Groseilliers S; Martin L; Ferland É; Vuong T
    Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):497-8. PubMed ID: 21576010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.